Chikungunya virus is a member of the Togaviridae family, and belongs to the Alphavirus genus. Its name is translated from the African dialect of Makonde which means, 'that which bends up' 1 and refers to the effect of the incapacitating arthralgia experienced by the majority of patients with CHIKV fever. This arthralgia affects the small joints of the hands, wrists, ankles, and feet. The arthritislike symptoms are accompanied by other symptoms such as maculopapular rash, myalgia, nausea, headaches, nasal discharge, conjunctivitis, retrobulbar pain, photophobia, and lymphadenopathy 1 . In the majority of cases recovery is achieved within 10 days; however, in some people the joint pain may persist for months (even years) 1 .
CHIKV is transmitted to people from its natural reservoirs, which include monkeys, rodents, bats, and birds, and subsequently between people by the bite of two types of mosquitos: Aedes aegypti 
Antibodies
Neutralising antibodies have been found to be effective in animal models of CHIKV infection 14, 15 . In rhesus monkeys, administration of monoclonal antibody (mAb), SVIR001 that mimics the human anti-CHIKV mAb 4N12, resulted in rapid clearance of CHIKV infec- 
